Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood

Department of Biochemistry and Molecular Biology, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, United States
Blood (Impact Factor: 10.45). 05/2005; 105(7):2783-6. DOI: 10.1182/blood-2004-08-3057
Source: PubMed


Endothelial progenitor cells (EPCs) can be isolated from adult peripheral and umbilical cord blood and expanded exponentially ex vivo. In contrast, human umbilical vein endothelial cells (HUVECs) or human aortic endothelial cells (HAECs) derived from vessel walls are widely considered to be differentiated, mature endothelial cells (ECs). However, similar to adult- and cord blood-derived EPCs, HUVECs and HAECs derived from vessel walls can be passaged for at least 40 population doublings in vitro. Based on this paradox, we tested whether EPCs reside in HUVECs or HAECs utilizing a novel single cell deposition assay that discriminates EPCs based on their proliferative and clonogenic potential. We demonstrate that a complete hierarchy of EPCs can be identified in HUVECs and HAECs derived from vessel walls and discriminated by their clonogenic and proliferative potential. This study provides evidence that a diversity of EPCs exists in human vessels and provides a conceptual framework for determining both the origin and function of EPCs in maintaining vessel integrity.

Download full-text


Available from: Mervin C Yoder, Jun 19, 2014
  • Source
    • "However, incubation of the cell homogenate with hydrogen peroxide and oxLDL does not affect the activity of the enzyme, which indicates that the inactivation of TERT is not directly related to the oxidation process. The authors suggest that the cause of telomerase activity reduction may be the deactivation of the protein kinase B (also known as Akt), responsible for the phosphorylation of the TERT subunit (Ingram et al., 2005). The inhibition of telomerase activity seems to be mediated by reduction of Akt phosphorylation, resulting in the deactivation of the kinase. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Oxidative stress can be induced by increased concentrations of iron in the body and consequently can cause shortening of telomeres. Telomeres, called mitotic clocks, are non-coding fragments at the end of chromosomes. During the replication of genetic material they are shortened, playing the role of ageing biomarkers in eukaryotes. In human endothelial cells, oxidative stress causes a decrease in telomerase activity. Shortening of chromosomes in telomeric parts was found in patients with primary hemochromatosis and in patients taking supplements containing iron. Increased level of transferrin saturation is associated with the presence of shorter telomeres in the chromosomes of leukocytes. The relationship between iron status and telomere length is still not fully understood.
    10/2015; 40(3):931-935. DOI:10.1016/j.etap.2015.10.002
    • "However, the extent and type of vascular intima repair or regeneration seems to be dependent on the extent and type of injury and the age of the host. Although, the presence of the whole hierarchical structure of endothelial populations within vessel walls, enabling for regeneration, have been shown [42] still there "
    [Show abstract] [Hide abstract]
    ABSTRACT: Endothelial progenitor cells (EPCs) have been extensively studied for almost 19 years now and were considered as a potential marker for endothelial regeneration ability. On the other hand, circulating endothelial cells (CEC) were studied as biomarker for endothelial injury. Yet, in the literature, there is also huge incoherency in regards to terminology and protocols used. This results in misleading conclusions on the role of so called "EPCs", especially in the clinical field. The discrepancies are mainly due to strong phenotypic overlap between EPCs and circulating angiogenic cells (CAC), therefore changes in "EPC" terminology have been suggested. Other factors leading to inconsistent results are varied definitions of the studied populations and the lack of universal data reporting, which could strongly affect data interpretation. The current review is focused on controversies concerning the use of "EPCs"/CAC and CEC as putative endothelial diagnostic markers. Copyright © 2015 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
    Pharmacological reports: PR 06/2015; 67(4). DOI:10.1016/j.pharep.2015.05.017 · 1.93 Impact Factor
  • Source
    • "It has been reported that AEA is involved in tumorangiogenesis and can be produced in different sources of endothelial progenitor cells (EPCs) including human peripheral blood, umbilical cord and aortic derived endothelial cells (Opitz et al., 2007; Pisanti et al., 2007; Pisanti et al., 2011). The so called vessel wall-derived endothelial colony-forming cells (ECFCs) are a subtype of EPCs that have a high clonogenic and proliferation potential and show a robust vessel-forming capacity in vivo (Ingram et al., 2005; Yoder et al., 2007; Reinisch et al., 2009). These characteristics make ECFCs a favorable cellular tool to study the potential influence of AEA on cell behavior and yield a promising target for pro-and anti-angiogenic therapies. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Anandamide (N-arachidonyl ethanolamide, AEA) is an endogenous cannabinoid that is involved in various pathological conditions, including cardiovascular diseases and tumor-angiogenesis. Herein, we tested the involvement of classical cannabinoid receptors (CBRs) and the Ca(2+)-channel transient receptor potential vanilloid 1 (TRPV1) on cellular AEA uptake and its effect on endothelial cell proliferation and network-formation. Uptake of the fluorescence-labeled anandamide (SKM4-45-1) was monitored in human endothelial colony-forming cells (ECFCs) and a human endothelial-vein cell line (EA.hy926). Involvement of the receptors during AEA translocation was determined by selective pharmacological inhibition (AM251, SR144528, CID16020046, SB366791) and molecular interference by TRPV1-selective siRNA-mediated knock-down and TRPV1 overexpression. We show that exclusively TRPV1 contributes essentially to AEA transport into endothelial cells in a Ca(2+)-independent manner. This TRPV1 function is a prerequisite for AEA-induced endothelial cell proliferation and network-formation. Our findings point to a so far unknown moonlighting function of TRPV1 as Ca(2+)-independent contributor/regulator of AEA uptake. We propose TRPV1 as representing a promising target for development of pharmacological therapies against AEA-triggered endothelial cell functions, including their stimulatory effect on tumor-angiogenesis.
    Biology Open 11/2014; 3(12). DOI:10.1242/bio.20149571 · 2.42 Impact Factor
Show more